Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity

被引:19
作者
Rencz, F. [1 ,2 ]
Hollo, P. [3 ]
Karpati, S. [3 ]
Pentek, M. [1 ]
Remenyik, E. [4 ,5 ]
Szegedi, A. [4 ,5 ]
Balogh, O. [1 ]
Heredi, E. [4 ,5 ]
Herszenyi, K. [3 ]
Jokai, H. [3 ]
Brodszky, V. [1 ]
Gulacsi, L. [1 ]
机构
[1] Corvinus Univ Budapest, Dept Hlth Econ, Budapest, Hungary
[2] Semmelweis Univ, Doctoral Sch Clin Med, H-1085 Budapest, Hungary
[3] Semmelweis Univ, Dept Dermatol Venereol & Dermatooncol, H-1085 Budapest, Hungary
[4] Univ Debrecen, Dept Dermatol, Debrecen, Hungary
[5] Univ Debrecen, Dept Dermatol Allergol, Debrecen, Hungary
基金
匈牙利科学研究基金会;
关键词
REPORTED OUTCOMES; ADALIMUMAB TREATMENT; IMPAIRMENT; IMPROVEMENT; MORTALITY; THERAPY; IMPACT; LENGTH; DLQI;
D O I
10.1111/jdv.12884
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundUnrealistic expectations regarding treatments and clinical outcomes may lead to disappointment about therapy and sub-optimal compliance; nonetheless, these expectations have not been studied in psoriasis patients yet. ObjectiveTo evaluate psoriasis patients' subjective future expectations regarding health-related quality of life (HRQOL) and life expectancy, and to explore clinical features associated with under- or overestimating behaviour. MethodsA cross-sectional questionnaire survey of consecutive adult patients with moderate to severe psoriasis was conducted. HRQOL expectations were recorded by applying the EQ-5D descriptive system for 6months ahead and for future ages of 60, 70, 80 and 90 respectively. ResultsIn total, 167 patients (71% males) were included in the analysis with mean age of 50.412.4years and mean EQ-5D score of 0.71 +/- 0.30. Overall 65% had chronic plaque psoriasis, 35% nail psoriasis, 35% scalp involvement, 29% psoriatic arthritis, 9% inverse psoriasis and 5% palmoplantar psoriasis respectively (combinations occurred). Participants expected 0.1 +/- 0.23 mean improvement in EQ-5D within 6months (P<0.001) that achieves the minimum clinically important difference. Overall 37% expected improvement and 13% decline; however, 49% expected no changes in any of the five dimensions of EQ-5D within 6months. Female gender, inverse or palmoplantar involvement and more severe psoriasis were likely associated with higher expectations. Patients at the initiation of their first biological at the time of the survey expected 0.18 +/- 0.24 increase that seems to be realistic compared to the EQ-5D utility gain achieved in randomized controlled trials. Males expected by 2.7 +/- 11.1 more, while females expected by 5.2 +/- 9.3 less life years compared to the average statistical gender- and age-matched life expectancy (P<0.05). Patients who expected to be alive at ages of 60, 70, 80 and 90 scored their future EQ-5D at ages of 60 to 90: 0.59 +/- 0.46, 0.48 +/- 0.41, 0.42 +/- 0.41 and 0.22 +/- 0.47 respectively. ConclusionOur findings highlight the importance of exploring expectations that might help to increase patients' compliance.
引用
收藏
页码:1398 / 1405
页数:8
相关论文
共 32 条
[1]   Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK [J].
Abuabara, K. ;
Azfar, R. S. ;
Shin, D. B. ;
Neimann, A. L. ;
Troxel, A. B. ;
Gelfand, J. M. .
BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (03) :586-592
[2]   Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study [J].
Ahlehoff, O. ;
Skov, L. ;
Gislason, G. ;
Lindhardsen, J. ;
Kristensen, S. L. ;
Iversen, L. ;
Lasthein, S. ;
Gniadecki, R. ;
Dam, T. N. ;
Torp-Pedersen, C. ;
Hansen, P. R. .
JOURNAL OF INTERNAL MEDICINE, 2013, 273 (02) :197-204
[3]  
Augustin M, 2013, CURR PROBL DERMATOL, V44, P74, DOI 10.1159/000350555
[4]   Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres [J].
Balogh, Orsolya ;
Brodszky, Valentin ;
Gulacsi, Laszlo ;
Heredi, Emese ;
Herszenyi, Krisztina ;
Jokai, Hajnalka ;
Karpati, Sarolta ;
Baji, Petra ;
Remenyik, Eva ;
Szegedi, Andrea ;
Hollo, Peter .
EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 :S101-S109
[5]   Chronic disease influences over 40 major life-changing decisions (MLCDs): a qualitative study in dermatology and general medicine [J].
Bhatti, Z. U. ;
Finlay, A. Y. ;
Bolton, C. E. ;
George, L. ;
Halcox, J. P. ;
Jones, S. M. ;
Ketchell, R. I. ;
Moore, R. H. ;
Salek, M. S. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (10) :1344-1355
[6]   What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature [J].
Bronsard, V. ;
Paul, C. ;
Prey, S. ;
Puzenat, E. ;
Gourraud, P-A ;
Aractingi, S. ;
Aubin, F. ;
Bagot, M. ;
Cribier, B. ;
Joly, P. ;
Jullien, D. ;
Le Maitre, M. ;
Richard-Lallemand, M-A ;
Ortonne, J-P .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 :17-22
[7]   Expectations regarding length and health related quality of life: Some empirical findings [J].
Brouwer, WBF ;
van Exel, NJA .
SOCIAL SCIENCE & MEDICINE, 2005, 61 (05) :1083-1094
[8]   Quality of life in patients with psoriasis: A systematic literature review [J].
de Korte, J ;
Sprangers, MAG ;
Mombers, FMC ;
Bos, JD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (02) :140-147
[9]   DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].
FINLAY, AY ;
KHAN, GK .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216
[10]   The risk of mortality in patients with psoriasis - Results from a population-based study [J].
Gelfand, Joel M. ;
Troxel, Andrea B. ;
Lewis, James D. ;
Kurd, Shanu Kohli ;
Shin, Daniel B. ;
Wang, Xingmei ;
Margolis, David J. ;
Strom, Brian L. .
ARCHIVES OF DERMATOLOGY, 2007, 143 (12) :1493-1499